The E3 Ligase Itch and Deubiquitinase Cyld Act Together to Regulate Tak1 and Inflammation

Nature Immunology - United Kingdom
doi 10.1038/ni.2157
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The E3 Ligase Tripartite Motif 8 Targets TAK1 to Promote Insulin Resistance and Steatohepatitis

Hepatology
MedicineHepatology
2017English

The E3 Ubiquitin Ligase Itch Is Required for B-Cell Development

Scientific Reports
Multidisciplinary
2019English

The Deubiquitinase USP9X Regulates the Stability and Function of E3 Ubiquitin Ligase RNF115 in Breast Cancer Cells

Cancer Science
Cancer ResearchMedicineOncology
2019English

Human ITCH E3 Ubiquitin Ligase Deficiency Causes Syndromic Multisystem Autoimmune Disease

American Journal of Human Genetics
Genetics
2010English

Activation of the E3 Ubiquitin Ligase Itch Through a Phosphorylation-Induced Conformational Change

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

DPPA2/4 and SUMO E3 Ligase PIAS4 Opposingly Regulate Zygotic Transcriptional Program

PLoS Biology
ImmunologyMolecular BiologyGeneticsBiochemistryMicrobiology Biological SciencesAgriculturalNeuroscience
2019English

PC-1 Works in Conjunction With E3 Ligase CHIP to Regulate Androgen Receptor Stability and Activity

Oncotarget
Oncology
2016English

Targeting Hedgehog Signalling Through the Ubiquitylation Process: The Multiple Roles of the HECT-E3 Ligase Itch

Cells
2019English

The Nedd4-Binding Partner 1 (N4BP1) Protein Is an Inhibitor of the E3 Ligase Itch

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy